Intranasal Insulin for Improving Cognitive Function in Multiple Sclerosis

The requested reference [07725c1feb5b1c52657faabc92b93a3e02fc0d49] no longer exists in our database. It has been replaced by the current reference: [6afaaeb805a0e7e0fd77b2070dc8bf22f379f400]

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2016
This study will evaluate if giving insulin that is administered in the nostrils (intranasal) is safe and tolerable for people with multiple sclerosis (MS). It is also being done to evaluate if intranasal insulin improves cognitive function in people with MS and to evaluate how it might be working.
Epistemonikos ID: 6346b53723eff92c4bd0803091f106f664ccd601
First added on: Mar 31, 2022